Skip to content

EndoRotor® 3.2mm Powered Endoscopic Debridement (PED) Catheter – Gastroscope Oly 3.2-PED-EGD-OPRecalls & reported problems

Interscope, Inc · EndoRotor® 3.2mm Powered Endoscopic Debridement (PED) Catheter – Gastroscope Olympus/Pentax · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00854172008193), received between Dec 1, 2023 and Dec 1, 2023 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 1 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Pancreatitis1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 1, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT ON (B)(6). 2023 A PANCREATIC NECROSECTOMY WAS PERFORMED ON A PATIENT. THIS WAS THE PATIENT'S 3RD DEBRIDEMENT USING THE ENDOROTOR DEVICE. THE PHYSICIAN STATED THAT ONCE THE THERAPEUTIC SCOPE WAS IN THE NECROTIC CAVITY, THE ENDOROTOR WAS PREPPED. NO OTHER CONVENTIONAL INSTRUMENTS WERE USED PRIOR TO THE USE OF THE ENDOROTOR CATHETER. AFTER ABOUT 15-20 MINUTES OF DEBRIDEMENT USING THE ENDOROTOR CATHETER, THE PHYSICIAN IMMEDIATELY RECOGNIZED SIGNIFICANT BLEED. THE CATHETER WAS QUICKLY REMOVED, AND THE PATIENT'S BLEEDING WAS TENDED TO. THE PATIENT DID NOT REQUIRE TREATMENT TO CONTROL THE BLEEDING AND THE SOURCE OF THE BLEEDING WAS NOT IDENTIFIED. THE BLEEDING CONTINUED FOR ABOUT 40 MINUTES AND THEN SUBSIDED. AFTER THE SCOPE WAS REMOVED, THE PATIENT WAS TRANSPORTED TO THE INTENSIVE CARE UNIT. THE PHYSICIAN STATED THERE WERE NO NOTICEABLE VESSELS AND/OR VISIBLE RISKS DURING THE DEBRIDEMENT. THE PHYSICIAN ADDED THAT THE PATIENT DID NOT HAVE ANY PANCREAS LEFT AND HE AND HIS TEAM WERE AWARE THAT THERE COULD BE VESSELS IN THE NECROTIC CAVITY. THE FOLLOWING MORNING, THE PHYSICIAN FOLLOWED UP AND STATED THAT THE PATIENT WAS STABLE. IT IS SUSPECTED THAT THE BLEEDING STEMMED F

    Patient problems: Pancreatitis

    MAUDE report 18245773 ↗

Other Endoscopic Morcellator Gastroenterology devices

All Endoscopic Morcellator Gastroenterology devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page